tradingkey.logo

Puma Biotechnology Inc <PBYI.OQ> expected to post a loss of 2 cents a share - Earnings Preview

ReutersMay 6, 2025 10:58 PM
  • Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • The Los Angeles California-based company is expected to report a 1.7% increase in revenue to $44.55 million from $43.8 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Puma Biotechnology Inc is for a loss of 2 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 20.8% in the last three months. ​

  • Wall Street's median 12-month price target for Puma Biotechnology Inc is $5.50​, above​ its last closing price of $2.98. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

0.11

0.10

0.39

Beat

279.9

Sep. 30 2024

0.34

0.35

0.41

Beat

16.9

Jun. 30 2024

-0.13

-0.13

-0.09

Beat

30.6​

Mar. 31 2024

-0.22

-0.22

-0.10

Beat

53.8

​​Dec. 31 2023

0.32

0.30

0.26

Missed

-13.2

Sep. 30 2023

0.08

0.08

0.12

Beat

56.5​

Jun. 30 2023

0.01

0.01

0.05

Beat

566.7

Mar. 31 2023

-0.07

-0.07

0.03

Beat

142.9

This summary was machine generated May 6 at 22:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI